Accession | Disease | Description | Year | Source | RNA-Seq | Count | Biomarkers |
GSE50236 | Prostate Cancer | Baseline serum anti-glycan total Ig antibodies of 113 subjects in a clinical trial of PROSTVAC-VF, a therapeutic cancer vaccine. (Dilution = 1:50) | 2013 | Serum | N | 113 | |
GSE39688 | Prostate Cancer | Immune response biomarker profiling of serum from prostate cancer patients treated with anti-CTLA-4 immunotherapy. | 2012 | Blood | N | 22 | |